Nutritional Cell Cycle and Differentiation Control
Nutritional Cell Cycle and Differentiation Control
批准号:
7176138
负责人:
ANDREW YEN
金额:
$25.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-08-01 至 2009-01-31
关键词:
76-kDa SH2 domain-containing leukocyte proteinAcidsAdolescentAntibodiesBLR1 geneBLR1 proteinBiologicalCD32 AntigensCSF1R geneCalciumCell CycleCell Cycle ArrestCell Differentiation processCell LineCell Surface ReceptorsCellsClassComplexCoupledCyclic ADP-RiboseDevelopmentDietary FactorsDifferentiation and GrowthEctopic ExpressionEmbryonic DevelopmentGene ExpressionGenesGlycoproteinsGrowthHL60HematopoieticHeterotrimeric GTP-Binding ProteinsHourHumanHydrolysisKineticsLCP2 geneLaboratoriesMAP Kinase GeneMAPK1 geneMeasuresMembraneMyelogenousNutritionalPlatelet-Derived Growth FactorProteinsProteomicsPublishingReceptor Protein-Tyrosine KinasesReceptor SignalingSignal TransductionSignaling MoleculeStimulation of Cell ProliferationSurveysTestingTretinoinVitamin AWorkbasecell growthchemotherapeutic agentimmunoglobulin receptorin vitro Modelin vivoleukemiamRNA Differential Displaysmorphogensneoplastic cellpaxillinprecursor cellprotein expressionreceptorresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The proposed studies focus on one aspect of the complex mechanism by which retinoic acid (RA) regulates cell growth and differentiation. RA is the active metabolite of a dietary factor, vitamin A, necessary for proper development in juveniles; a morphogen during embryogenesis; and a chemotherapeutic agent regulating growth and differentiation of neoplastic cells. The studies utilize HL-60 human leukemia cells, an uncommitted hematopoietic precursor cell that can undergo myeloid or monocytic differentiation and GO arrest. RA causes MAPK signaling dependent myeloid differentiation and GO arrest of these cells. The studies will determine the contribution of RA-induced expression of selected membrane receptors and adapter signaling molecules to the unanticipated activation of MAPK signaling and to the diversity of gene expression changes caused by RA. They thus focus on two basic biological questions: 1) what is the significance of MAPK signaling in Ra-induced growth arrest and differentiation when such signaling is usually considered the prototypical signal for mitogenesis; 2) how are the diverse sequential gene expression changes needed to evoke growth arrest and differentiation generated by RA. Searches by our laboratory, as well as others, using a combination of differential display, a proteomics based differential search, or querying candidate molecules revealed that RA induces the expression of four receptors, c-FMS, BLR1, CD32, and CD38, which differ significantly in character. The downstream signaling consequences of these receptors are thus likely to differ and regulate the expression of different ensembles of genes. However, a common feature of these receptors is that all have been implicated with utilizing MAPK signaling. RA also induces the expression of several adapter molecules, in particular paxillin, SLP-76, and dok. These, too, have been connected with MAPK signaling and in some cases explicitly to some of the aforementioned receptors. The working hypothesis is that RA induces the expression of cell surface receptors, whose signaling is regulated by adapter molecules, resulting in MAPK signal activation and consequential changes in protein expression ultimately leading to GO arrest and differentiation. Different combinations of receptors and adapters then direct changes in the expression of different ensembles of proteins, each combination contributing to the total changes attributed to RA. The experimental aims are to ectopically express these receptors and adapters, singly and in combination, to determine their ability to stimulate MAPK signaling and cause gene expression changes that contribute to the total RA-induced changes, and to test the functional significance of their induced expression to RA-induced differentiation or GO arrest.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Retinoic Acid Regulated Cell Differentiation: BLR1 Rcptr
-
批准号:7094902
-
项目类别:
-
资助金额:$11.85万
-
财政年份:2005
-
负责人:ANDREW YEN
-
依托单位:
FLUORESCENCE ACTIVATED CELL SORTER: INFECTIOUS DISEASE
-
批准号:6973184
-
项目类别:
-
资助金额:$8.22万
-
财政年份:2004
-
负责人:ANDREW YEN
-
依托单位:
FLUORESCENCE ACTIVATED CELL SORTER: CELL BIOLOGY
-
批准号:6973185
-
项目类别:
-
资助金额:$19.18万
-
财政年份:2004
-
负责人:ANDREW YEN
-
依托单位:
FLUORESCENCE ACTIVATED CELL SORTER: CANCER
-
批准号:6973187
-
项目类别:
-
资助金额:$10.96万
-
财政年份:2004
-
负责人:ANDREW YEN
-
依托单位:
FLUORESCENCE ACTIVATED CELL SORTER: IMMUNOLOGY
-
批准号:6973186
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2004
-
负责人:ANDREW YEN
-
依托单位:
Fluorescence activated cell sorter
-
批准号:6740017
-
项目类别:
-
资助金额:$45.67万
-
财政年份:2004
-
负责人:ANDREW YEN
-
依托单位:
TOPOISOMERASES IN RETINOID INDUCED DIFFERENTIATION
-
批准号:6350747
-
项目类别:
-
资助金额:$30.87万
-
财政年份:2000
-
负责人:ANDREW YEN
-
依托单位:
TOPOISOMERASES IN RETINOID INDUCED DIFFERENTIATION
-
批准号:6041299
-
项目类别:
-
资助金额:$30.64万
-
财政年份:2000
-
负责人:ANDREW YEN
-
依托单位:
TOPOISOMERASES IN RETINOID INDUCED DIFFERENTIATION
-
批准号:6628575
-
项目类别:
-
资助金额:$32.46万
-
财政年份:2000
-
负责人:ANDREW YEN
-
依托单位:
TOPOISOMERASES IN RETINOID INDUCED DIFFERENTIATION
-
批准号:6498177
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2000
-
负责人:ANDREW YEN
-
依托单位:
LASER CYTOMETER CELL SORTER
-
批准号:2284268
-
项目类别:
-
资助金额:$30.0万
-
财政年份:1994
-
负责人:ANDREW YEN
-
依托单位:
FLUORESCENCE ACTIVATED CELL SORTER/FLOW CYTOMETER
-
批准号:3519706
-
项目类别:
-
资助金额:$25.0万
-
财政年份:1987
-
负责人:ANDREW YEN
-
依托单位:
PRE-COMMITMENT REGULATION OF CELL DIFFERENTIATION
-
批准号:3180368
-
项目类别:
-
资助金额:$9.17万
-
财政年份:1985
-
负责人:ANDREW YEN
-
依托单位:
PRE-COMMITMENT REGULATION OF CELL DIFFERENTIATION
-
批准号:3180363
-
项目类别:
-
资助金额:$9.17万
-
财政年份:1985
-
负责人:ANDREW YEN
-
依托单位:
PRE-COMMITMENT REGULATION OF CELL DIFFERENTIATION
-
批准号:3180369
-
项目类别:
-
资助金额:$4.18万
-
财政年份:1985
-
负责人:ANDREW YEN
-
依托单位:
PRE-COMMITMENT REGULATION OF CELL DIFFERENTIATION
-
批准号:3180370
-
项目类别:
-
资助金额:$4.39万
-
财政年份:1985
-
负责人:ANDREW YEN
-
依托单位:
CELL CYCLE SPECIFIC CONTROL OF DIFFERENTIATION
-
批准号:2088538
-
项目类别:
-
资助金额:$21.34万
-
财政年份:1983
-
负责人:ANDREW YEN
-
依托单位:
Nutritional Cell Cycle and Differentiation Control
-
批准号:7009274
-
项目类别:
-
资助金额:$26.7万
-
财政年份:1983
-
负责人:ANDREW YEN
-
依托单位:
Nutritional Cell Cycle and Differentiation Control
-
批准号:8208043
-
项目类别:
-
资助金额:$25.53万
-
财政年份:1983
-
负责人:ANDREW YEN
-
依托单位:
CELL CYCLE SPECIFIC CONTROL OF CELLULAR DIFFERENTIATION
-
批准号:3171350
-
项目类别:
-
资助金额:$10.84万
-
财政年份:1983
-
负责人:ANDREW YEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: